Search

Author/Creator Reger, Robert

1. 1072. SARS-CoV-2 Antibody Levels Associate with Neutrophil Activation. (15th December 2022)

Authors:
Warner, Seth; Miao, Rui; Ramos-Benitez, Marcos J; Tian, Xin; Reger, Robert; Burbelo, Peter D; Kanthi, Yogendra; Kanthi, Yogendra; Cohen, Jeffrey I; Suffredini, Anthony F; Nathan, Steven D; Childs, Richard W; Childs, Richard W; Childs, Richard W; Chertow, Daniel S; Strich, Jeffrey R
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo‐immunized patients. (21st February 2020)

Authors:
Vo, Phuong; Purev, Enkhtsetseg; West, Kamille A.; McDuffee, Emily; Worthy, Tatyana; Cook, Lisa; Hawks, Geri; Wells, Brian; Shalabi, Reem; Flegel, Willy A.; Adams, Sharon D.; Reger, Robert; Aue, Georg; Tian, Xin; Childs, Richard
Journal:
British journal of haematology
Issue:
Volume 189:Number 3(2020)
Page Start:
551
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome. (15th May 2021)

Authors:
Childs, Richard W.; Tian, Xin; Vo, Phuong; Purev, Enkhtsetseg; Kotecha, Ritesh R.; Carlsten, Mattias; Clara, Joseph; Flegel, Willy A.; Adams, Sharon D.; Khuu, Hanh M.; Stroncek, David F.; Cook, Lisa; Worthy, Tat'yana; Geller, Nancy L.; Wells, Brian; Wilder, Jennifer; Reger, Robert; Aue, Georg
Journal:
British journal of haematology
Issue:
Volume 193:Number 5(2021)
Page Start:
951
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized Trial. (28th August 2021)

Authors:
Strich, Jeffrey R; Tian, Xin; Samour, Mohamed; King, Christopher S; Shlobin, Oksana; Reger, Robert; Cohen, Jonathan; Ahmad, Kareem; Brown, A Whitney; Khangoora, Vikramjit; Aryal, Shambhu; Migdady, Yazan; Kyte, Jennifer Jo; Joo, Jungnam; Hays, Rebecca; Collins, A Claire; Battle, Edwinia; Valdez, J...
Journal:
Clinical infectious diseases
Issue:
Volume 75:Number 1(2022)
Page Start:
e491
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. High-affinity CD16 integration into a CRISPR/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells. Issue 2 (8th February 2022)

Authors:
Clara, Joseph Andrew; Levy, Emily R; Reger, Robert; Barisic, Stefan; Chen, Long; Cherkasova, Elena; Chakraborty, Mala; Allan, David S J; Childs, Richard
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 2(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. LIR‐1 educates expanded human NK cells and defines a unique antitumor NK cell subset with potent antibody‐dependent cellular cytotoxicity. Issue 10 (5th October 2021)

Authors:
Leijonhufvud, Caroline; Reger, Robert; Segerberg, Filip; Theorell, Jakob; Schlums, Heinrich; Bryceson, Yenan T; Childs, Richard W; Carlsten, Mattias
Journal:
Clinical & translational immunology
Issue:
Volume 10:Issue 10(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗